Yirui Biotechnology (300942.SZ) released the 2024 interim report. During the reporting period, the company achieved revenue...
Zhixun Finance and Economics APP news, Yirui Biotechnology (300942.SZ) released the 2024 interim report. During the reporting period, the company achieved revenue of 104 million yuan, a 7.55% year-on-year decrease. The net loss attributable to shareholders of the listed company was 1.5595 million yuan, a 97.76% year-on-year decrease. Excluding non-recurring gains and losses, the net loss attributable to shareholders of the listed company was 5.2591 million yuan, a 93.04% year-on-year decrease. Basic loss per share was 0.0039 yuan.